Ryan Specialty Stock In Shambles: Down -7.4% With 8-Day Losing Streak

RYAN: Ryan Specialty logo
RYAN
Ryan Specialty

Ryan Specialty (RYAN) – a provider of specialty insurance products and solutions – hit a 8-day losing streak, with cumulative losses over this period amounting to -7.4%. The company’s market cap has crashed by about $346 Mil over the last 8 days and currently stands at $4.3 Bil.

Is this opportunity or trap? There are only a couple of things to fear in RYAN stock given its overall Strong operating performance and financial condition. Hence, together with its High valuation, this makes the stock look Risky (For details, see Buy or Sell RYAN).

But here is the interesting part. You are reading about this -7.4% move after it happened. The market has already priced in the news. To manage individual stock risk before the headlines, you need predictive signals, not notifications. High Quality Portfolio has a risk model designed to manage stock-specific drawdowns better.

Trefis: RYAN Stock Insights

Returns vs S&P 500

Relevant Articles
  1. ADBE Stock: Where Compounding Could Take The Price
  2. The Power Problem Powering FuelCell’s Rally
  3. China Is Coming For Micron’s Thick Margins
  4. SpaceX’s Next Big Bet: Your Phone Bill?
  5. The Billion-Dollar Asterisk On Nike
  6. Marvell Stock And The High-Stakes Forecast Behind The AI Story

The following table summarizes the return for RYAN stock vs. the S&P 500 index over different periods, including the current streak:

Return Period RYAN S&P 500
1D -0.1% 0.0%
8D (Current Streak) -7.4% -1.1%
1M (21D) -13.8% -4.8%
3M (63D) -35.4% -4.7%
YTD 2026 -34.9% -4.2%
2025 -18.9% 16.4%
2024 50.9% 23.3%
2023 3.6% 24.2%

Gains and Losses Streaks: S&P 500 Constituents

There are currently 160 S&P constituents with 3 days or more of consecutive gains and 35 constituents with 3 days or more of consecutive losses.
 

Consecutive Days # of Gainers # of Losers
3D 128 14
4D 12 8
5D 18 1
6D 0 6
7D or more 2 6
Total >=3 D 160 35

 
 
Key Financials for Ryan Specialty (RYAN)

Last 2 Fiscal Years:

Metric FY2024 FY2025
Revenues $2.5 Bil $3.1 Bil
EBT $272.6 Mil $293.2 Mil
Net Income $94.7 Mil $63.4 Mil

Last 2 Fiscal Quarters:

Metric 2025 FQ3 2025 FQ4
Revenues $754.6 Mil $751.2 Mil
EBT $59.8 Mil $44.6 Mil
Net Income $31.1 Mil $8.0 Mil

The losing streak RYAN stock is currently on doesn’t inspire much confidence among investors. In contrast, Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.